Science at Sanofi
Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas
Learn more about these therapeutic areas
Choose one of the following therapeutic areas in which we are dedicated at Sanofi
Science
We offer you a 360º view of relevant and trustworthy content in our therapeutic areas
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP
An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.
VESTIGE Trial Results: Dupilumab in Type 2 Asthma
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP
An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.
VESTIGE Trial Results: Dupilumab in Type 2 Asthma
This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.
New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention
Events
Stay up to date and register for the latest events and view webinar recordings
Safe & Smart: Cardio Safe & Gluco Smart Approach in Diabetes Management
This engagement will address the unmet medical needs in diabetes quinary management through Multidisciplinary Team of top experts in the field of endocrinology and internal medicine in Gulf, India, Levant and Egypt.
.png/jcr:content/Updates-on-the-causes-and-treatments-of-schizophrenia-thumb%20(1).png)
Sir Robin Murray updates us on Schizophrenia and it’s treatments
Updates on the Causes and Treatments of Schizophrenia
World Diabetes Day
Dr. Hussein Elbadawi talks about Hypoglycemia and how is it classified.
Safe & Smart - Dr. Salah
Dr. Salah gives us the updated guidelines on Sulphonylureas and Cardiovascular safety
Safe & Smart - Dr. Nabil
Dr. Nabil talks about Sulphonylureas within treatment landscape in Ramadan
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Ministry of Health organizes 'KiDS' program at Expo 2020 Dubai to promote diabetes awareness at schools
